Qnexa is the third diet pill to be rejected by the FDA

Published: October 28, 2020

Qnexa is the latest in a long line of quick fix diet pills aimed at combating obesity.  The combination drug is manufactured by Vivux Inc. of California and their test pills easily passed the FDA’s requirements.

The FDA rules that anti-obesity drugs must cause at least a 5% body weight loss in a third of its test subjects to be considered for release as a prescription drug, something which Qnexa easily managed.  Despite meeting the requirements the FDA rejected the drug over concerns about safety, citing risks to the heart and other major organs as the reason for their decision.

The setback for Vivus and their wonder pill Qnexa comes at a time when the FDA has tightened its belt over such drugs, Qnexa being the third this month.  Vivus were confident that the combination of Phentermine  (a weight loss stimulant) and Topiramate (an anti-convulsant drug used in epilepsy treatment) would yield great results in the nation’s battle against increasing obesity cases.

An alternative to drug assisted weight loss is a change of diet and exercise.  Although most diets require a good level of commitment, there are many proven, healthy diets for people to try such as 50% raw vegan which can be supplemented by organic meat products.

Food manufacturing, in the US especially, is big business and a quick scan of the ingredients on any frozen food package or ‘junk’ food carton will give you a good idea as to why there is so much obesity these days.  That’s before looking at fast food ingredients.

Most products are full of chemicals as indicated by E numbers and sugars which the body is unable to break down leaving fatty deposits which obviously leads to weight gain.  On the other hand raw and organic food steers away from such things, leaving foods in their natural state meaning that the nutrients, friendly bacteria and enzymes remain intact which is far more beneficial to the body.

Combine that healthier calorific intake with an hour long walk everyday or yoga three times per week and you’ve found yourself a drug free combination for improving health and losing weight.  It may take longer to see the results but once the weight is lost it tends to stay gone.

Anti-convulsants or fresh air and organic food?  Let us know your opinion by leaving a comment.

Read about celebs who have lost weight such as Anthony Hopkins, Kelly Osbourne, 50 cent - or look at our Yoga selections like Bikram, Kundalini, Iyengar and Ashtanga Vinyasa.

images: www.sxc.hu



Tweet this


Published October 28, 2020 by in Health Conditions
Tags: , , , , , ,

36 Responses to “Qnexa is the third diet pill to be rejected by the FDA”

  1. Noelia Gaukroger

    09. Sep, 2011

    I got what you mean , appreciate it for putting up.Woh I am delighted to find this website through google.

    Reply to this comment
  2. [...] our previous article on Qnexa, weight loss pills, check out some alternative diets like vegan, vegetarian, raw, spectrum and [...]

    Reply to this comment
  3. Niche Blogs

    10. Nov, 2010

    Hi, Your blog very informative. Thanks for sharing.I\’m added your blog name http://www.celebrities-with-diseases.com to my Niche Blogs Directory. Thankyou!

    Reply to this comment
  4. [...] problem that prevents them from losing weight. Such as PCOS so before you judge you need …Qnexa is the third diet pill to be rejected by the FDACelebrities With Diseasesall 634 news [...]

    Reply to this comment
  5. [...] Over Safety ConcernsBloombergVivus rallies as drug indexes easeMarketWatchSmartAboutHealth -Celebrities With Diseases -Forbes (blog)all 634 news [...]

    Reply to this comment
  6. [...] NewsQnexa diet drug not approved, but prospects are goodSeer PressBloomberg -MarketWatch -Celebrities With Diseasesall 634 news [...]

    Reply to this comment
  7. [...] BeastQnexa diet drug not approved, but prospects are goodSeer PressTopNews United States -Celebrities With Diseases -San Diego Union Tribuneall 634 news [...]

    Reply to this comment
  8. [...] Approval for Diet Pill Qnexa Over Safety ConcernsBloombergMarketWatch -SmartAboutHealth -Celebrities With Diseasesall 634 news [...]

    Reply to this comment
  9. [...] Over Safety ConcernsBloombergVivus rallies as drug indexes easeMarketWatchSmartAboutHealth -Celebrities With Diseasesall 634 news [...]

    Reply to this comment
  10. [...] Approval for Diet Pill Qnexa Over Safety ConcernsBloombergMarketWatch -SmartAboutHealth -Celebrities With Diseasesall 634 news [...]

    Reply to this comment
  11. [...] Over Safety ConcernsBloombergVivus rallies as drug indexes easeMarketWatchSmartAboutHealth -Celebrities With Diseasesall 634 news [...]

    Reply to this comment
  12. [...] Over Safety ConcernsBloombergVivus rallies as drug indexes easeMarketWatchSmartAboutHealth -Celebrities With Diseasesall 634 news [...]

    Reply to this comment
  13. [...] Over Safety ConcernsBloombergVivus rallies as drug indexes easeMarketWatchSmartAboutHealth -Celebrities With Diseases -Forbes (blog)all 634 news [...]

    Reply to this comment
  14. [...] Over Safety ConcernsBloombergVivus rallies as drug indexes easeMarketWatchSmartAboutHealth -Celebrities With Diseases -Forbes (blog)all 634 news [...]

    Reply to this comment
  15. [...] Over Safety ConcernsBloombergVivus rallies as drug indexes easeMarketWatchSmartAboutHealth -Celebrities With Diseases -Forbes (blog)all 634 news [...]

    Reply to this comment
  16. Qnexa pill

    29. Oct, 2010

    Judging on what i am reading here about the Qnexa pill, I would not be surprised if the FDA approves it eventually with strict labeling on it, due to its high effectiveness.

    Reply to this comment
  17. guy erewen

    29. Oct, 2010

    The relatively benign CRL for Qnexa is not really surprising. VVUS is an FDA/Wall St./media darling.

    David Orloff had been promoting the concept of combination therapies since at least 2004 while he was still at the FDA. When he suddenly resigned from the FDA in the middle of controversy over questionable drug approvals in his office, he was fortunate to get a job at Medpace.

    While at Medpace, Dr. Orloff oversaw clinical trials of Qnexa and “crafted” the Qnexa NDA, which was reviewed at the FDA by Eric Colman, the person who Orloff had supervised and worked closely with while at the FDA.

    The fact that Qnexa does not meet the requirements for combination therapies based on the component efficacies does not matter. The fact that the advisory committee panel requested additional clinical trials for cardiovascular concerns does not matter. The fact that topiramate causes cognitive problems and birth defects does not matter.

    This drug was a foregone decision that has been in the works at FDA since at least 2004, where it was discussed by the theraputics subcommittee at the FDA obesity working group.

    An FDA official tainted by scandal, leaving to test a drug already being discussed by FDA, and submitting the application for approval back to the same office where he worked, for review by his former associate, reeks of cronyism.

    Cheers to your good news today VVUS shareholders! Qnexa will be approved soon, but as a citizen I am sadly disappointed in our FDA drug approval process.

    The relatively benign CRL for Qnexa is not really surprising. VVUS is an FDA/Wall St./media darling.

    David Orloff had been promoting the concept of combination therapies since at least 2004 while he was still at the FDA. When he suddenly resigned from the FDA in the middle of controversy over questionable drug approvals in his office, he was fortunate to get a job at Medpace.

    While at Medpace, Dr. Orloff oversaw clinical trials of Qnexa and “crafted” the Qnexa NDA, which was reviewed at the FDA by Eric Colman, the person who Orloff had supervised and worked closely with while at the FDA.

    The fact that Qnexa does not meet the requirements for combination therapies based on the component efficacies does not matter. The fact that the advisory committee panel requested additional clinical trials for cardiovascular concerns does not matter. The fact that topiramate causes cognitive problems and birth defects does not matter.

    This drug was a foregone decision that has been in the works at FDA since at least 2004, where it was discussed by the theraputics subcommittee at the FDA obesity working group.

    An FDA official tainted by scandal, leaving to test a drug already being discussed by FDA, and submitting the application for approval back to the same office where he worked, for review by his former associate, reeks of cronyism.

    Cheers to your good news today VVUS shareholders! Qnexa will be approved soon, but as a citizen I am sadly disappointed in our FDA drug approval process.

    Reply to this comment
  18. [...] rejects highly-anticipated diet drug QnexaThe Associated PressBloomberg -New York Times -Celebrities With Diseasesall 421 news [...]

    Reply to this comment
  19. [...] rejects highly-anticipated diet drug QnexaThe Associated PressBloomberg -New York Times -Celebrities With Diseasesall 422 news [...]

    Reply to this comment
  20. [...] rejects highly-anticipated diet drug QnexaThe Associated PressBloomberg -New York Times -Celebrities With Diseasesall 421 news [...]

    Reply to this comment
  21. [...] rejects highly-anticipated diet drug QnexaThe Associated PressBloomberg -New York Times -Celebrities With Diseasesall 421 news [...]

    Reply to this comment
  22. [...] rejects highly-anticipated diet drug QnexaThe Associated PressBloomberg -New York Times -Celebrities With Diseasesall 421 news [...]

    Reply to this comment
  23. [...] rejects highly-anticipated diet drug QnexaThe Associated PressBloomberg -New York Times -Celebrities With Diseasesall 415 news [...]

    Reply to this comment
  24. [...] rejects highly-anticipated diet drug QnexaThe Associated PressBloomberg -New York Times -Celebrities With Diseasesall 415 news [...]

    Reply to this comment
  25. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA denies approval for highly touted diet drugBusinessWeekFDA rejects highly-anticipated diet drug QnexaThe Associated PressVivus Fails to Win US Approval for Diet Pill Qnexa Over Safety ConcernsBloombergNew York Times -Forbes (blog) -Daily Beastall 383 news articles » [...]

    Reply to this comment
  26. [...] Safety ConcernsBloombergFDA Rejects Another Weight-Loss DrugMedPage TodayThe Associated Press -Celebrities With Diseases -Daily Beastall 383 news [...]

    Reply to this comment
  27. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA denies approval for highly touted diet drugBusinessWeekFDA rejects highly-anticipated diet drug QnexaThe Associated PressVivus Fails to Win US Approval for Diet Pill Qnexa Over Safety ConcernsBloombergNew York Times -Forbes (blog) -MedPage Todayall 383 news articles » [...]

    Reply to this comment
  28. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA denies approval for highly touted diet drugBusinessWeek [...]

    Reply to this comment
  29. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA denies approval for highly touted diet drugBusinessWeekFDA rejects highly-anticipated diet drug QnexaThe Associated PressVivus Fails to Win US Approval for Diet Pill Qnexa Over Safety ConcernsBloombergNew York Times -Forbes (blog) -MedPage Todayall 376 news articles » [...]

    Reply to this comment
  30. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA denies approval for highly touted diet drugBusinessWeekFDA rejects highly-anticipated diet drug QnexaThe Associated PressVivus Fails to Win US Approval for Diet Pill Qnexa Over Safety ConcernsBloombergNew York Times -Forbes (blog) -MedPage Todayall 375 news articles » [...]

    Reply to this comment
  31. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA Rejects Vivus's Obesity Drug QnexaWall Street JournalFDA Rejects Qnexa, a Third Weight-Loss DrugNew York TimesVivus Fails to Win US Approval for Diet Pill Qnexa Over Safety ConcernsBloombergFierceBiotech -MedPage Today -The Associated Pressall 374 news articles » [...]

    Reply to this comment
  32. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA denies approval for highly touted diet drugBusinessWeekVivus Fails to Win US Approval for Diet Pill Qnexa Over Safety ConcernsBloombergFDA Rejects Qnexa, a Third Weight-Loss DrugNew York TimesThe Associated Press -Forbes (blog) -Forexyardall 374 news articles » [...]

    Reply to this comment
  33. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA Rejects Vivus's Obesity Drug QnexaWall Street JournalFDA Rejects Qnexa, a Third Weight-Loss DrugNew York TimesVivus Fails to Win US Approval for Diet Pill Qnexa Over Safety ConcernsBloombergFierceBiotech -MedPage Today -The Associated Pressall 374 news articles » [...]

    Reply to this comment
  34. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA Rejects Vivus's Obesity Drug QnexaWall Street JournalFDA Rejects Qnexa, a Third Weight-Loss DrugNew York TimesVivus Fails to Win US Approval for Diet Pill Qnexa Over Safety ConcernsBloombergFierceBiotech -MedPage Today -The Associated Pressall 374 news articles » [...]

    Reply to this comment
  35. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA Rejects Vivus's Obesity Drug QnexaWall Street JournalFDA Rejects Qnexa, a Third Weight-Loss DrugNew York TimesVivus Fails to Win US Approval for Diet Pill Qnexa Over Safety ConcernsBloombergFierceBiotech -MedPage Today -The Associated Pressall 374 news articles » [...]

    Reply to this comment
  36. [...] Qnexa is the third diet pill to be rejected by the FDACelebrities With DiseasesQnexa is the latest in a long line of quick fix diet pills aimed at combating obesity. The combination drug is manufactured by Vivux Inc. of California and …FDA Rejects Vivus's Obesity Drug QnexaWall Street JournalFDA Rejects Qnexa, a Third Weight-Loss DrugNew York TimesVivus Fails to Win US Approval for Diet Pill Qnexa Over Safety ConcernsBloombergFierceBiotech -MedPage Today -The Associated Pressall 374 news articles » [...]

    Reply to this comment

Leave a Reply